TBPB,
634616-95-8,
1-(1'-(2-methylbenzyl)-1,4'-bipiperidin-4-yl)-1H-benzo[d]imidazol-2(3H)-one,
CHEMBL522460,
3-[1-[1-[(2-methylphenyl)methyl]piperidin-4-yl]piperidin-4-yl]-1H-benzimidazol-2-one,
GTPL3258,
SCHEMBL5473311,
CWPKTBMRVATCBL-UHFFFAOYSA-N,
BCP13406,
TBPB, >=98% (HPLC),
2-Pyrrolo-1,3,2-dioxa-phospholan,
BDBM50263887,
ZINC40423557,
AKOS026750197,
2-pyrrol-1-yl-1,3,2-dioxaphospholan,
API0014162,
CS-3517,
NCGC00390669-01,
DA-41854,
HY-14562,
QC-11734,
FT-0746315,
Y6339,
A14205,
BRD-K86989957-001-01-7,
1-(1''-(2-methylbenzyl)-1,4''-bipiperidin-4-yl)-1H-benzo[d]imidazol-2(3H)-one,
1-(1''-2-methylbenzyl)-1,4''-bipiperidin-4-yl)-1H-benzo[d]imidazol-2(3H)-one,
1-(1'-(2-Methylbenzyl)-[1,4'-bipiperidin]-4-yl)-1H-benzo[d]imidazol-2(3H)-one,
1-[1-[1-(2-Methylbenzyl)piperidin-4-yl]piperidin-4-yl]-1,3-dihydro-2H-benzimidazol-2-one,
TBPB(1-(1'-(2-methylbenzyl)-1,4'-bipiperidin-4-yl)-1H-benzo[d]imidazol-2(3H)-one),
BQCA,
D0M2LD,
benzyl quinolone carboxylic acid,
C25H32N4O,
CID10092649,
B4828,
M1mAChRs (neurological disorder), Merck & Co,
M1 muscarinic acetylcholine receptor agonist (Alzherimer's disease),
3-[1-[1-[(2-methylphenyl)methyl]-4-piperidyl]-4-piperidyl]-1H-benzoimidazol-2-one,
M1 muscarinic acetylcholine receptor agonist (Alzherimer's disease), Merck & Co,
TBPB1-(1-(2-Methylbenzyl)-1,4-bipiperidin-4-yl)-1H-benzo[d]imidazol-2(3H)-one,